Dr Peter Barlow: «Dr Peter Barlow is funded by a grant from the Chief Scientist Office (Scotland) on a project
investigating novel therapeutic approaches for respiratory viral infections.»
Not exact matches
Our group has 3 major goals: Develop
novel therapeutic approaches based on centrosomal clustering To further develop our first prototype inhibitors of centrosomal clustering preclinically and to establish a robust and specific high throughput small molecule screen Discover key events in myeloma pathogenesis To
investigate the pivotal transition from the pre-malignant, asymptomatic to malignant, symptomatic stages of plasma cell dyscrasias in order to understand the pathophysiology and thereby identify
novel targets Translate small molecule therapeutics from bench to clinical trials To evaluate
novel agents in the preclinical setting and to initiate early phase clinical trials in hematologic malignancies with focus on multiple myeloma
The goal of her laboratory is to combine high - resolution computational reconstructions of the microbiome with synthetic biology to devise innovative
approaches to create
novel therapeutic interventions and
investigate the underlying ecology of skin microbial communities.
Together with our collaborators in other UT Health San Antonio departments, we are currently
investigating if prohibiting the accumulation of DNA abnormalities can be used as a
novel therapeutic approach for treating MDS.
Here, we
investigate the hypothesis that miR - 181a regulates the molecular pathways that control mDA axonal growth, and provide evidence that miR - 181a inhibition may be a
novel therapeutic approach for axonal regeneration in PD.